SE9201413L - Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet - Google Patents

Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet

Info

Publication number
SE9201413L
SE9201413L SE9201413A SE9201413A SE9201413L SE 9201413 L SE9201413 L SE 9201413L SE 9201413 A SE9201413 A SE 9201413A SE 9201413 A SE9201413 A SE 9201413A SE 9201413 L SE9201413 L SE 9201413L
Authority
SE
Sweden
Prior art keywords
preparation
pct
blood
platelet concentrate
methods
Prior art date
Application number
SE9201413A
Other languages
English (en)
Other versions
SE9201413D0 (sv
Inventor
Svante Jonsson
Original Assignee
Stiftelsen Foer Medicinsk Tekn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiftelsen Foer Medicinsk Tekn filed Critical Stiftelsen Foer Medicinsk Tekn
Priority to SE9201413A priority Critical patent/SE9201413L/sv
Publication of SE9201413D0 publication Critical patent/SE9201413D0/sv
Priority to EP93912059A priority patent/EP0649311B1/en
Priority to AU43535/93A priority patent/AU4353593A/en
Priority to US08/884,358 priority patent/US5899874A/en
Priority to DE69327651T priority patent/DE69327651T2/de
Priority to PCT/SE1993/000383 priority patent/WO1993021935A1/en
Priority to CA002134759A priority patent/CA2134759A1/en
Publication of SE9201413L publication Critical patent/SE9201413L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9201413A 1992-04-30 1992-04-30 Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet SE9201413L (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9201413A SE9201413L (sv) 1992-04-30 1992-04-30 Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet
EP93912059A EP0649311B1 (en) 1992-04-30 1993-04-30 Method for production of platelet concentrates with significantly prolonged viability during storage
AU43535/93A AU4353593A (en) 1992-04-30 1993-04-30 Preparation and method for production of platelet concentrates with significantly prolonged viability during storage
US08/884,358 US5899874A (en) 1992-04-30 1993-04-30 Preparation and method for production of platelet concentrates with significantly prolonged viabilty during storage
DE69327651T DE69327651T2 (de) 1992-04-30 1993-04-30 Methode zur produktion von plättchenkonzentraten mit signifikant erhöhter lebensfähigkeit während der lagerung
PCT/SE1993/000383 WO1993021935A1 (en) 1992-04-30 1993-04-30 Preparation and method for production of platelet concentrates with significantly prolonged viability during storage
CA002134759A CA2134759A1 (en) 1992-04-30 1993-04-30 Preparation and method for production of platelet concentrates with significantly prolonged viability during storage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201413A SE9201413L (sv) 1992-04-30 1992-04-30 Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet

Publications (2)

Publication Number Publication Date
SE9201413D0 SE9201413D0 (sv) 1992-04-30
SE9201413L true SE9201413L (sv) 1993-10-31

Family

ID=20386151

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201413A SE9201413L (sv) 1992-04-30 1992-04-30 Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet

Country Status (7)

Country Link
US (1) US5899874A (sv)
EP (1) EP0649311B1 (sv)
AU (1) AU4353593A (sv)
CA (1) CA2134759A1 (sv)
DE (1) DE69327651T2 (sv)
SE (1) SE9201413L (sv)
WO (1) WO1993021935A1 (sv)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6102926A (en) 1996-12-02 2000-08-15 Angiotrax, Inc. Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use
US6051008A (en) 1996-12-02 2000-04-18 Angiotrax, Inc. Apparatus having stabilization members for percutaneously performing surgery and methods of use
US6120520A (en) * 1997-05-27 2000-09-19 Angiotrax, Inc. Apparatus and methods for stimulating revascularization and/or tissue growth
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6432119B1 (en) 1999-03-17 2002-08-13 Angiotrax, Inc. Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
WO2002005866A2 (en) * 2000-07-13 2002-01-24 Bioheart, Inc. Deployment system for myocardial cellular material
US6548241B1 (en) * 2000-11-28 2003-04-15 Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
US7264608B2 (en) 2001-12-05 2007-09-04 Fenwal, Inc. Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US6905612B2 (en) * 2003-03-21 2005-06-14 Hanuman Llc Plasma concentrate apparatus and method
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
DE10392686T5 (de) 2002-05-24 2005-07-07 Biomet Mfg. Corp., Warsaw Vorrichtung und Verfahren zum Trennen und Konzentrieren von Flüssigkeiten, welche mehrere Komponenten enthalten
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US20080299538A1 (en) * 2003-02-28 2008-12-04 Caridianbct Biotechnologies, Llc Pathogen Inactivation of Whole Blood
US8308708B2 (en) * 2003-07-15 2012-11-13 Abbott Cardiovascular Systems Inc. Deployment system for myocardial cellular material
US20050137517A1 (en) * 2003-12-19 2005-06-23 Baxter International Inc. Processing systems and methods for providing leukocyte-reduced blood components conditioned for pathogen inactivation
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
PL1848473T3 (pl) * 2005-02-07 2013-11-29 Hanuman Llc Urządzenie - koncentrator osocza
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
EP2227268B2 (en) 2007-10-24 2023-08-23 Nikkiso Co., Ltd. Optimizing clearance for protein bound molecules using cascade filtration therapy
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
WO2009111338A1 (en) * 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US20100081985A1 (en) * 2008-10-01 2010-04-01 Caridianbct, Inc. Platelet Additive Solution For Leukoreducing White Blood Cells In Apheresed Platelets
EP2211046B1 (en) 2008-12-29 2011-03-02 C.R.F. Società Consortile per Azioni Fuel injection system with high repeatability and stability of operation for an internal-combustion engine
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8834402B2 (en) * 2009-03-12 2014-09-16 Haemonetics Corporation System and method for the re-anticoagulation of platelet rich plasma
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US11864553B2 (en) 2009-10-23 2024-01-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9555171B2 (en) 2010-09-30 2017-01-31 Depuy Mitek, Llc Methods and devices for collecting separate components of whole blood
US8808978B2 (en) 2010-11-05 2014-08-19 Haemonetics Corporation System and method for automated platelet wash
US9302042B2 (en) 2010-12-30 2016-04-05 Haemonetics Corporation System and method for collecting platelets and anticipating plasma return
WO2012125955A2 (en) 2011-03-16 2012-09-20 Mayo Foundation For Medical Education And Research Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations
US9402866B2 (en) 2011-04-07 2016-08-02 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329986A (en) * 1979-06-14 1982-05-18 Biomedics, Inc. Treatment of an extracorporeal stream of blood with a dialyzable chemotherapeutic and a fluorescable tracer
EP0107688B1 (en) * 1982-04-28 1986-10-01 The Trustees Of The Garfield Weston Trust For Research Into Heart Surgery Processes for the production of blood products
US4500309A (en) * 1982-05-07 1985-02-19 The Kansas University Endowment Association Method for regional anticoagulation during extracorporeal dialysis
CA1244774A (en) * 1983-11-09 1988-11-15 Thomas Jefferson University Medium for storing blood platelets
US4769318A (en) * 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
CA2067134C (en) * 1989-10-06 2001-02-13 Harold T. Meryman Procedure for storing red cells with prolonged maintenance of cellular concentrations of atp and 2,3 dpg
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen

Also Published As

Publication number Publication date
US5899874A (en) 1999-05-04
WO1993021935A1 (en) 1993-11-11
EP0649311A1 (en) 1995-04-26
AU4353593A (en) 1993-11-29
DE69327651T2 (de) 2000-12-07
CA2134759A1 (en) 1993-11-11
SE9201413D0 (sv) 1992-04-30
DE69327651D1 (de) 2000-02-24
EP0649311B1 (en) 2000-01-19

Similar Documents

Publication Publication Date Title
SE9201413L (sv) Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet
Haynes et al. Clinical use of glycerolized frozen blood
ATE206897T1 (de) Extrakorporal-anwendbare einmalleitung zur überwachung von blut-bestandteilen
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ES8403321A1 (es) Procedimiento para la produccion de un preparado solido de fibrinogeno.
Van de Watering et al. Effects of storage of red cells
EP0226085A3 (en) Cardio pulmonary system intended for oxygenation of a patient's blood
Ambrus et al. Role of the lungs in regulation of the white blood cell level
Tamari et al. Functional changes in platelets during extracorporeal circulation
JPS6363616A (ja) 赤血球濃厚液の保存剤及び保存方法
US20040120937A1 (en) Blood therapy process
Heath et al. Treatment of antidepressant poisoning with resin hemoperfusion
Boycott The Blood as a Tissue; Hypertrophy and Atrophy of the Red Corpuscles
Haag-Weber et al. Impaired cellular host defence in peritoneal dialysis by two granulocyte inhibitory proteins
Edvardsen et al. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates
Patt et al. Hemodynamics in pulmonary irritant poisoning
Hall et al. Anticoagulation by ancrod for haemodialysis
ATE183204T1 (de) Aminozucker, glycoproteine, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung
Cohen et al. Platelets and atherogenesis. I. Augmentation of cholesterol atherogenesis in the rabbit by a phlebotomy programme designed to induce thrombocytosis
SU1775897A1 (ru) Способ получения диагностического агента для определения протромбинового времени
Lewis et al. Severe haemoptysis associated with viral tracheitis
Symbas et al. Left ventricular function during acute ethanol intoxication and hemodialysis
ATE184107T1 (de) Verfahren und zusammensetzung zum lysieren von erythrozyten, blutzusammensetzungen und verfahren zur leukozytanalyse
Heal et al. Harvesting of committed hematopoietic progenitor cells (CFU‐GM) by hemapheresis
Ortega et al. A beneficial effect of the in situ kidney on in vitro marrow erythropoiesis in chronic renal failure

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9201413-3

Format of ref document f/p: F